메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Meltem Agca (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur) Eylem Tuncay (Department of Respiratory Intensive Care Unit University of Health Sciences Sureyyapasa Chest Disea) Elif Yıldırım (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur) Reyhan Yıldız (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur) Tulin Sevim (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur) Dilek Ernam (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur) Nermin Ozer Yılmaz (Department of Infectious Diseases University of Health Sciences Sureyyapasa Chest Diseases and Thor) Nazlı Huma Teke (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur) Simge Yavuz (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur) Zuhal Karakurt (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur) Ipek Ozmen (Department of Pulmonology University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Sur)
저널정보
대한감염학회 Infection and Chemotherapy Infection and Chemotherapy 제53권 제2호
발행연도
2021.1
수록면
319 - 331 (13page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. Materials and Methods In this retrospective study we analyzed patients with positive polymerase chain reaction test in tertiary care hospital between March-May 2020. They were divided into 3 groups according to body mass index (BMI) as normal, overweight, and obese (BMI: 18.5 - 24.99 kg/m2, 25 - 29.99 kg/m2, and ≥ 30 kg/m2, respectively). We compared clinical features and laboratory findings of these groups and recorded adverse clinical outcomes. Multivariate logistic analysis was performed for unfavorable outcomes. Results There were 99 patients (35%), 116 (41%), and 69 patients (24%) in the normal-weight, overweight, and obese group, respectively. Among all patients, 52 (18%) patients were transferred to the intensive care unit (ICU), 30 (11%) patients received invasive mechanical ventilation (IMV), and 22 patients (8%) died. Obese patients had minimum 1 more comorbidity than normal BMI patients (73% vs. 50%, P = 0.002), and a longer median (interquartile range [IQR]) duration of hospitalization (8 [5 - 12] vs. 6 [5 - 9]) days, P = 0.006). Obese participants had higher concentrations of serum C-reactive protein, procalcitonin, ferritin than non-obese patients (P <0.05 in all). In a multivariate analysis, obesity was associated with ICU admission (adjusted odds ratio [aOR]: 2.99, 95% confidence interval [CI]: 1.26 - 7.04, P = 0.012). Moreover, IMV requirement was associated with obesity (aOR: 8.73, 95% CI: 2.44 - 31.20, P = 0.001). Mortality occurred in 16%, 9%, and 1% of the obese group, overweight group, and normal-weight group, respectively (Chi-square trend analysis, P = 0.002). Conclusion Obesity is a risk factor for adverse outcomes and caused increased mortality, hence requiring close follow-up.
#Body mass index #COVID-19 #Intensive care unit #Obesity #SARS-CoV-2

목차

등록된 정보가 없습니다.

참고문헌 (31)

참고문헌 신청
World Health Organization (WHO) / Novel coronavirus (2019-nCoV): situation report-11 google schola World Health Organization (WHO) / Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update google schola Republic of Turkey Ministry: COVID-19 information page google schola Wu Z / 2020 / Characteristics of and Important lessons from the coronavirus disease 2019(COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention / JAMA 323:1239~1242 google schola Yang J / 2020 / Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis / Int J Infect Dis 94:91~95 google schola

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0